Several other research analysts also recently commented on ESRX. William Blair downgraded shares of Express Scripts from an outperform rating to a market perform rating in a report on Thursday. Zacks Investment Research raised shares of Express Scripts from a hold rating to a buy rating and set a $84.00 price target for the company in a report on Tuesday, March 6th. Barclays assumed coverage on shares of Express Scripts in a report on Thursday. They issued an equal weight rating and a $84.00 price target for the company. Maxim Group downgraded shares of Express Scripts from a buy rating to a hold rating in a report on Thursday. Finally, Jefferies Group downgraded shares of Express Scripts from a buy rating to a hold rating and set a $91.00 price objective for the company. in a report on Thursday. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of Hold and a consensus target price of $81.97.
Express Scripts (NASDAQ ESRX) opened at $80.75 on Thursday. The company has a quick ratio of 0.55, a current ratio of 0.67 and a debt-to-equity ratio of 0.83. Express Scripts has a fifty-two week low of $55.80 and a fifty-two week high of $85.07. The company has a market cap of $45,320.00, a price-to-earnings ratio of 10.43, a price-to-earnings-growth ratio of 0.99 and a beta of 0.94.
Express Scripts declared that its Board of Directors has approved a share repurchase program on Monday, December 18th that allows the company to repurchase 45,000,000 outstanding shares. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s leadership believes its shares are undervalued.
In related news, VP Glen D. Stettin sold 3,449 shares of Express Scripts stock in a transaction on Thursday, January 11th. The shares were sold at an average price of $81.00, for a total value of $279,369.00. Following the transaction, the vice president now owns 33,715 shares in the company, valued at approximately $2,730,915. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Christine Houston sold 10,104 shares of Express Scripts stock in a transaction on Friday, December 15th. The stock was sold at an average price of $70.08, for a total transaction of $708,088.32. Following the completion of the transaction, the vice president now owns 87,400 shares in the company, valued at approximately $6,124,992. The disclosure for this sale can be found here. In the last quarter, insiders sold 21,896 shares of company stock worth $1,617,903. 0.68% of the stock is owned by corporate insiders.
Large investors have recently modified their holdings of the stock. Fairfield Bush & CO. purchased a new position in shares of Express Scripts in the fourth quarter valued at about $226,000. Xact Kapitalforvaltning AB increased its position in shares of Express Scripts by 5.2% in the fourth quarter. Xact Kapitalforvaltning AB now owns 102,730 shares of the company’s stock valued at $7,668,000 after acquiring an additional 5,123 shares during the period. Envestnet Asset Management Inc. increased its position in shares of Express Scripts by 52.3% in the fourth quarter. Envestnet Asset Management Inc. now owns 179,586 shares of the company’s stock valued at $13,404,000 after acquiring an additional 61,657 shares during the period. CNB Bank purchased a new position in shares of Express Scripts in the fourth quarter valued at about $326,000. Finally, Hikari Tsushin Inc. purchased a new position in shares of Express Scripts in the fourth quarter valued at about $1,344,000. Institutional investors own 87.70% of the company’s stock.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.